Actively Recruiting
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
Led by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Updated on 2024-04-23
40
Participants Needed
1
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, single-arm exploratory study to evaluate the efficacy and safety of chemotherapy combined with Adebrelimab and Apatinib as the perioperative treatment in Patients With Biliary Tract Cancer.
CONDITIONS
Official Title
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed intrahepatic cholangiocarcinoma
- Tumor lesion that can be surgically removed
- No contraindications to surgery
- High risk of tumor recurrence
- No prior systemic therapy for intrahepatic cholangiocarcinoma
- ECOG Performance Status of 0 or 1
- Child-Pugh Class Grade A
You will not qualify if you...
- History of gastrointestinal hemorrhage within 6 months prior to study treatment or a clear tendency for gastrointestinal hemorrhage
- Abdominal fistula, gastrointestinal perforation, or intraperitoneal abscess within 6 months prior to study treatment
- Known genetic or acquired bleeding or clotting disorders
- Thrombosis or thromboembolic events within 6 months prior to study treatment
- Uncontrolled cardiac symptoms or disease
- Hypertension not well controlled by medication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou, China/Guangdong, China
Actively Recruiting
Research Team
Y
Yajin Chen
CONTACT
C
Changzhen shang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here